Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Erectile Dysfunction Drugs Companies

ID: MRFR/Pharma/0805-HCR
80 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Pharmaceutical companies were actively involved in the development, manufacturing, and marketing of drugs for the treatment of erectile dysfunction (ED).
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Erectile Dysfunction Drugs Market

Market Size

Forecast Period2026 - 2035
CAGR (2026 - 2035)4.43%
2025 Market Size$ 3.1 Billion
2026 Market Size$ 3.4 Billion
2035 Market Size$ 10.2 Billion

Key Players

Top 10 ED medication companies are
Pfizer
Bayer
Eli Lilly
Boehringer Ingelheim
Teva Pharmaceuticals
Opportunities
  • Aging Population
  • Advancements in Drug Development
  • Increased Focus on Sexual Health

Top Industry Leaders in the Erectile Dysfunction Drugs Market

Erectile Dysfunction Drugs Key Companies
ย 
Latest Erectile Dysfunction Drugs Companies Update

Petros Pharmaceuticals launched two self-selection studies for its ED medication STENDRA (avanafil) in January 2022. These studies aim to gather patient preferences and improve treatment decisions.

Lupin Limited received FDA approval to market Sildenafil for oral suspension, 10 mg/mL, in September 2022. This new formulation caters to patients with swallowing difficulties.

Teva Pharmaceutical Industries announced Phase 3 results for its PDE5 inhibitor, Vestra, in May 2023. These results demonstrated efficacy and tolerability, potentially paving the way for market entry.

Apricus Biosciences launched Vitaros (testosterone gel) in the US in 2022. This new topical option expands treatment options for men with low testosterone contributing to ED.

List of Erectile Dysfunction Drugs Key Companies in the Market

  • Pfizer Inc. (U.S)

  • Apricus Biosciences Inc. (U.S).

  • Bayer AG (Germany)

  • Dongโ€“A Pharmaceutical Co. Ltd. (South Korea)

  • S.K. Chemicals Co. Ltd. (South Korea)

  • Eli Lily & Co. (U.S)

  • Apricus Biosciences Inc. (U.S)

  • Cristalia Produtos Quimicos Farmaceuticos Ltd.

  • Meda Pharmaceuticals, Inc.

  • S.K. Chemicals Co. Ltd.

  • Vivus Inc.

  • Teva Pharmaceutical Industries Ltd